{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:46:13Z","timestamp":1761821173769},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.jocn.2004.09.012","type":"journal-article","created":{"date-parts":[[2005,7,23]],"date-time":"2005-07-23T12:07:56Z","timestamp":1122120476000},"page":"669-672","source":"Crossref","is-referenced-by-count":10,"title":["Endothelial function markers in parkinsonian patients with hyperhomocysteinemia"],"prefix":"10.1016","volume":"12","author":[{"given":"Sevasti","family":"Bostantjopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Katsarou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Frangia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Hatzizisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Papazisis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kyriazis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Kiosseoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristidis","family":"Kazis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2004.09.012_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/014107680109400103","article-title":"Homocysteine \u2013 a novel risk factor for vascular disease","volume":"94","author":"Chambers","year":"2001","journal-title":"JR Soc Med"},{"key":"10.1016\/j.jocn.2004.09.012_bib2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","author":"Clarke","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2004.09.012_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-2000-8472","article-title":"Hyperhomocysteinemia, vascular pathology and endothelial dysfunction","volume":"26","author":"Van Guldener","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jocn.2004.09.012_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00019052-200102000-00015","article-title":"Homocysteine and stroke","volume":"14","author":"Hankey","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jocn.2004.09.012_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s004150050292","article-title":"Hyperhomocysteinaemia in Parkinson\u2019s disease","volume":"245","author":"Kuhn","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2004.09.012_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000007984","article-title":"Elevated plasma levels of homocysteine in Parkinson\u2019s disease","volume":"40","author":"Kuhn","year":"1998","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2004.09.012_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(99)01660-8","article-title":"Nigral endothelial dysfunction, homocysteine, and Parkinson\u2019s disease","volume":"354","author":"M\u00fcller","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2004.09.012_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/WNL.55.3.437","article-title":"Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD","volume":"55","author":"Yasui","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.09.012_bib9","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/clinchem\/47.6.1102","article-title":"Plasma homocysteine and L-Dopa metabolism in patients with Parkinson\u2019s disease","volume":"47","author":"Blandini","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.jocn.2004.09.012_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.60.1.59","article-title":"Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease","volume":"60","author":"Rogers","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2004.09.012_bib11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1212\/01.WNL.0000055899.24594.8E","article-title":"Effect of L-Dopa on plasma homocysteine in PD patients: relationship to B-vitamin status","volume":"60","author":"Miller","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.09.012_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/1531-8257(200101)16:1<119::AID-MDS1024>3.0.CO;2-W","article-title":"Stroke and idiopathic Parkinson\u2019s disease: Does a shortage of dopamine offer protection against stroke","volume":"16","author":"Korten","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2004.09.012_bib13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mds.10199","article-title":"Prevalence of stroke in Parkinson\u2019s disease: a postmortem study","volume":"17","author":"Mastaglia","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2004.09.012_bib14","first-page":"153","volume":"vol. 2","author":"Fahn","year":"1987"},{"key":"10.1016\/j.jocn.2004.09.012_bib15","first-page":"63","article-title":"Superoxide dismutase activity in early and advanced Parkinson\u2019s disease","volume":"12","author":"Bostantjopoulou","year":"1997","journal-title":"Funct Neurol"},{"key":"10.1016\/j.jocn.2004.09.012_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A canditate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jocn.2004.09.012_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s007020200013","article-title":"3-OMD and homocysteine plasma levels in parkinsonian patients","volume":"109","author":"M\u00fcller","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jocn.2004.09.012_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00002826-199702000-00007","article-title":"Effect of L-Dopa and the catechol \u2013 O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats","volume":"20","author":"Miller","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jocn.2004.09.012_bib19","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/S0024-3205(00)00557-9","article-title":"Effects of L-Dopa treatment on methylation in mouse brain: implications for the side effects of L-Dopa","volume":"66","author":"Liu","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.jocn.2004.09.012_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/clc.4960251105","article-title":"Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation","volume":"25","author":"Hirsh","year":"2002","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jocn.2004.09.012_bib21","series-title":"Homocysteine and Vascular Disease","first-page":"371","article-title":"Homocysteine and endothelial dysfunction","author":"Eberhardt","year":"2000"},{"key":"10.1016\/j.jocn.2004.09.012_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9150(99)00111-2","article-title":"Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital \u2013 based population","volume":"146","author":"Wang","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jocn.2004.09.012_bib23","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1161\/01.STR.31.8.1889","article-title":"Oxidative stress in the context of acute cerebrovascular stroke","volume":"31","author":"El Kossi","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2004.09.012_bib24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/hc3601.093976","article-title":"Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine. Amelioration of homocysteine induced endoplasmic reticulum stress by taurine","volume":"104","author":"Nonaka","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2004.09.012_bib25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.ATV.20.2.422","article-title":"Homocysteine \u2013 induced inhibition of endothelium \u2013 dependent relaxation in rabbit aorta: role for superoxide anions","volume":"20","author":"Lang","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jocn.2004.09.012_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0022-510X(88)90108-6","article-title":"Oxygen toxicity protecting enzymes in Parkinson\u2019s disease, Increase of superoxide dismutase \u2013 like activity in substantia nigra and basal nucleus","volume":"86","author":"Marttila","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2004.09.012_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02454194","article-title":"Serum antioxidant enzyme activity in Parkinson\u2019s disease","volume":"110","author":"Karla","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jocn.2004.09.012_bib28","first-page":"933","article-title":"Decreased superoxide dismutase activity in erythrocytes in Parkinson\u2019s disease","volume":"46","author":"Urakami","year":"1992","journal-title":"Jpn J Psychiatry Neurol"},{"key":"10.1016\/j.jocn.2004.09.012_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9150(97)00090-7","article-title":"Stimulation of endothelial nitric oxide production by homocysteine","volume":"132","author":"Upchurch","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jocn.2004.09.012_bib30","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","article-title":"Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase","volume":"272","author":"Upchurch","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jocn.2004.09.012_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)78090-9","article-title":"Acute hyperhomocysteinemia and endothelial dysfunction","volume":"351","author":"Chambers","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2004.09.012_bib32","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/01.CIR.96.8.2542","article-title":"Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in human","volume":"96","author":"Woo","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2004.09.012_bib33","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/01.CIR.95.5.1119","article-title":"Hyperhomocysteinemia is associated with impaired endothelium \u2013 dependent vasodilation in humans","volume":"95","author":"Tawakol","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2004.09.012_bib34","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/clinchem\/45.8.1200","article-title":"Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor, but not with endothelium-dependent vasodilation in healthy postmenopausal women","volume":"45","author":"De Valk-de Roo","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.jocn.2004.09.012_bib35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(03)00007-1","article-title":"Increased concentrations of homocysteine and asymmetric dimethyl-arginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer\u2019s disease","volume":"24","author":"Selley","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jocn.2004.09.012_bib36","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.ATV.0000035404.18281.37","article-title":"Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia","volume":"22","author":"Wang","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jocn.2004.09.012_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.ATV.0000014221.30108.08","article-title":"Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion","volume":"22","author":"Silverman","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jocn.2004.09.012_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.CIR.101.5.485","article-title":"Effects of methionine \u2013 induced hyperhomocysteinemia on endothelium \u2013 dependent vasodilation and oxidative status in healthy adults","volume":"101","author":"Chao","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2004.09.012_bib39","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2362.2000.00706.x","article-title":"Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects \u2013 The Hoorn Study","volume":"30","author":"Becker","year":"2000","journal-title":"Eur J Clin Invest"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586805001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586805001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:05:23Z","timestamp":1626217523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586805001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0967586805001499"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2004.09.012","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}